Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mail to Mr. West (analyst from Dutton)

"From May 2006 through February 29, 2008, Patriot received over $93.0 million net royalty fees from licenses and there is no reason to expect the royalties to cease."

No reason to expect royalties to cease??? How about: we haven't had a license signing in -- how long?

Is receiving a failed re-exam from the USPTO a reason to expect royalties to cease????

Not to be a downer but this might be the reason we're sitting at .21. If there were actually no reason for our royalty payments to cease, we would be a lot closer to $1.00 IMO.

Am I missing something?

Share
New Message
Please login to post a reply